Huahai Pharmaceutical to hold current convertible bond conversion price

Zhejiang Huahai Pharmaceutical Company Limited announced on November 5, 2025, its decision not to amend downwards the conversion price of its "Huahai convertible bonds" (bond code: 110076). This decision follows the company's stock price meeting the trigger for downward adjustment clauses, where the closing price fell below 80% of the current conversion price for at least 15 trading days within 30 consecutive trading days. The current conversion price is 33.06 yuan per share.

The company's board of directors, during its sixth interim meeting of the ninth board, approved this resolution. The board also committed not to propose a downward revision plan if the trigger conditions are met again within the next two months (November 6, 2025, to January 5, 2026). A new observation period will begin on January 6, 2026.

The convertible bonds, issued in 2020 with an initial conversion price of 34.66 yuan per share, have seen several adjustments due to profit distributions and restricted stock incentive plans, with the latest adjustment taking effect on July 10, 2025. This decision reflects the company's assessment of its intrinsic value and long-term development potential.